WHAT: An intensive one-day course designed to provide journalists new insights and knowledge into this emerging field that works to engineer organs and tissues in the laboratory and develop cell therapies to restore organ function. Attendees will learn about the science of regenerative medicine from a faculty that includes Robert Lanza, MD, and Anthony Atala, MD, and about the challenges of commercialization from the leaders of Integra and iPierian. Maggie Fox, health and science editor with Thomson Reuters, will moderate panels on commercialization and the future of regenerative medicine.
WHEN: Tuesday, April 6, at Benton Convention Center, in Winston-Salem, N.C. The cost is $200. A limited number of full scholarships, which include travel expenses and lodging, are available. Journalists attending the Media Academy are invited to also attend/cover the first Translational Regenerative Medicine Forum, April 7-8. This event will bring together scientists, venture capitalists, regulatory experts, clinicians, and biotech companies to discuss ways to advance the field, including business models and best practices. (www.rmconferences.org)
MEDIA ACADEMY FACULTY: The Science of Regenerative Medicine● Anthony Atala, M.D., Director, Wake Forest Institute for Regenerative Medicine. ● Robert Lanza, M.D., Chief Scientific Officer, Advanced Cell Technology. ● Buddy Ratner, Ph.D., Professor of Chemical Engineering and Bioengineering at the University of Washington.
Challenges of Commercialization● Tim Bertram, DVM, PhD, Sr. VP for Science and Technology, Tengion, Inc.● Richard Caruso, Ph.D., Founder and Board chairman, Integra.● John Walker, CEO, iPierian.
REGISTER: To register, and for more details about the program and speakers, go to www.wfubmc.edu/WFIRM/Media-Academy/Registration is limited to 30 journalists to ensure adequate time to interact with the experts.
SPONSORS: The event is sponsored by Wake Forest University Baptist Medical Center and the Regenerative Medicine Foundation.
RSS